Abstract
No public abstract is available from the verified source records.
Rushaniya Fazliyeva, Alexey Matveev, Ruslan Smetanin, Ilia Fedorov, Kathy Q. Cai, Alexander Kutikov, Robert G. Uzzo, Andrew Andrews, Peter Makhov, Vladimir M. Kolenko
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer
10.1097/pas.0000000000001476 · 2020
Renal cell carcinoma
10.1038/nrdp.2017.9 · 2017
Downstream targets of VHL/HIF-alpha signaling in renal clear cell carcinoma progression: mechanisms and therapeutic relevance
10.3390/cancers15041316 · 2023
Protein lysine acetylation by p300/CBP
10.1021/cr500452k · 2015
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
10.7150/thno.73223 · 2022
The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
10.1016/j.ctrv.2015.05.004 · 2015
LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma
10.1038/bjc.2017.77 · 2017
HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma
10.1158/1078-0432.ccr-19-1459 · 2020
The acetylase/deacetylase couple CREB-binding protein/sirtuin 1 controls hypoxia-inducible factor 2 signaling
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1074/jbc.m111.244780 · 2012
Coordinate regulation of stress signaling and epigenetic events by Acss2 and HIF-2 in cancer cells
10.1371/journal.pone.0190241 · 2017
HIF-2alpha expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma
10.1172/jci164249 · 2024
Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2
10.1073/pnas.0811023106 · 2009
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734
10.1182/bloodadvances.2020001879 · 2020
No additional external references are available.